nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS1—kidney cancer	0.563	0.636	CbGaD
Bromfenac—PTGS2—kidney cancer	0.322	0.364	CbGaD
Bromfenac—Corneal perforation—Erlotinib—kidney cancer	0.0168	0.232	CcSEcCtD
Bromfenac—Corneal disorder—Capecitabine—kidney cancer	0.00579	0.08	CcSEcCtD
Bromfenac—Ulcerative keratitis—Erlotinib—kidney cancer	0.00553	0.0765	CcSEcCtD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.0022	0.0627	CbGpPWpGaD
Bromfenac—Eye pruritus—Paclitaxel—kidney cancer	0.00182	0.0251	CcSEcCtD
Bromfenac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00175	0.0498	CbGpPWpGaD
Bromfenac—Swelling face—Paclitaxel—kidney cancer	0.00171	0.0236	CcSEcCtD
Bromfenac—Swelling face—Capecitabine—kidney cancer	0.0014	0.0194	CcSEcCtD
Bromfenac—Visual acuity reduced—Paclitaxel—kidney cancer	0.00137	0.0189	CcSEcCtD
Bromfenac—Photophobia—Vinblastine—kidney cancer	0.00137	0.0189	CcSEcCtD
Bromfenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—kidney cancer	0.00133	0.0378	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT8—kidney cancer	0.00117	0.0334	CbGpPWpGaD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.00116	0.0329	CbGpPWpGaD
Bromfenac—Visual acuity reduced—Capecitabine—kidney cancer	0.00112	0.0155	CcSEcCtD
Bromfenac—Epistaxis—Temsirolimus—kidney cancer	0.00103	0.0142	CcSEcCtD
Bromfenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—kidney cancer	0.000971	0.0276	CbGpPWpGaD
Bromfenac—Epistaxis—Pazopanib—kidney cancer	0.000968	0.0134	CcSEcCtD
Bromfenac—Eye irritation—Paclitaxel—kidney cancer	0.000952	0.0132	CcSEcCtD
Bromfenac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.000919	0.0262	CbGpPWpGaD
Bromfenac—Eye disorder—Temsirolimus—kidney cancer	0.000914	0.0126	CcSEcCtD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOSL1—kidney cancer	0.000909	0.0259	CbGpPWpGaD
Bromfenac—Mediastinal disorder—Temsirolimus—kidney cancer	0.000881	0.0122	CcSEcCtD
Bromfenac—Eye disorder—Pazopanib—kidney cancer	0.000861	0.0119	CcSEcCtD
Bromfenac—Mediastinal disorder—Pazopanib—kidney cancer	0.00083	0.0115	CcSEcCtD
Bromfenac—Eye irritation—Capecitabine—kidney cancer	0.000781	0.0108	CcSEcCtD
Bromfenac—Epistaxis—Everolimus—kidney cancer	0.000764	0.0106	CcSEcCtD
Bromfenac—PTGS2—Overview of nanoparticle effects—PTGS1—kidney cancer	0.00076	0.0216	CbGpPWpGaD
Bromfenac—Vision blurred—Pazopanib—kidney cancer	0.000756	0.0105	CcSEcCtD
Bromfenac—Cough—Temsirolimus—kidney cancer	0.000743	0.0103	CcSEcCtD
Bromfenac—Epistaxis—Erlotinib—kidney cancer	0.000737	0.0102	CcSEcCtD
Bromfenac—Balsalazide—PTGS1—kidney cancer	0.000737	0.0927	CrCbGaD
Bromfenac—Cough—Pazopanib—kidney cancer	0.0007	0.00968	CcSEcCtD
Bromfenac—Eye disorder—Everolimus—kidney cancer	0.00068	0.0094	CcSEcCtD
Bromfenac—Lumiracoxib—PTGS1—kidney cancer	0.000674	0.0848	CrCbGaD
Bromfenac—Epistaxis—Sorafenib—kidney cancer	0.000663	0.00917	CcSEcCtD
Bromfenac—Eye disorder—Erlotinib—kidney cancer	0.000656	0.00907	CcSEcCtD
Bromfenac—Mediastinal disorder—Everolimus—kidney cancer	0.000655	0.00906	CcSEcCtD
Bromfenac—Eye pain—Paclitaxel—kidney cancer	0.000653	0.00904	CcSEcCtD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.000652	0.0186	CbGpPWpGaD
Bromfenac—Nepafenac—PTGS1—kidney cancer	0.000641	0.0806	CrCbGaD
Bromfenac—Epistaxis—Sunitinib—kidney cancer	0.000638	0.00883	CcSEcCtD
Bromfenac—Mediastinal disorder—Erlotinib—kidney cancer	0.000632	0.00875	CcSEcCtD
Bromfenac—PTGS2—Eicosanoid Synthesis—PTGS1—kidney cancer	0.000631	0.018	CbGpPWpGaD
Bromfenac—Fenbufen—PTGS1—kidney cancer	0.000613	0.0771	CrCbGaD
Bromfenac—Vision blurred—Everolimus—kidney cancer	0.000597	0.00825	CcSEcCtD
Bromfenac—Pain—Temsirolimus—kidney cancer	0.000594	0.00821	CcSEcCtD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOSL1—kidney cancer	0.000588	0.0167	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—ROS1—kidney cancer	0.000585	0.0166	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—kidney cancer	0.000572	0.0163	CbGpPWpGaD
Bromfenac—Mediastinal disorder—Sorafenib—kidney cancer	0.000569	0.00787	CcSEcCtD
Bromfenac—Eye disorder—Sunitinib—kidney cancer	0.000568	0.00785	CcSEcCtD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000562	0.016	CbGpPWpGaD
Bromfenac—Pain—Pazopanib—kidney cancer	0.00056	0.00774	CcSEcCtD
Bromfenac—Cough—Everolimus—kidney cancer	0.000552	0.00764	CcSEcCtD
Bromfenac—Mediastinal disorder—Sunitinib—kidney cancer	0.000548	0.00757	CcSEcCtD
Bromfenac—PTGS1—Biological oxidations—ACY1—kidney cancer	0.000545	0.0155	CbGpPWpGaD
Bromfenac—Eye pain—Capecitabine—kidney cancer	0.000536	0.00742	CcSEcCtD
Bromfenac—Cough—Erlotinib—kidney cancer	0.000533	0.00737	CcSEcCtD
Bromfenac—Tolmetin—PTGS1—kidney cancer	0.000533	0.067	CrCbGaD
Bromfenac—Stinging—Doxorubicin—kidney cancer	0.000531	0.00734	CcSEcCtD
Bromfenac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.000528	0.015	CbGpPWpGaD
Bromfenac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.000517	0.0147	CbGpPWpGaD
Bromfenac—Suprofen—PTGS1—kidney cancer	0.000511	0.0642	CrCbGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—HSPB1—kidney cancer	0.000492	0.014	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—EIF4EBP1—kidney cancer	0.000492	0.014	CbGpPWpGaD
Bromfenac—Cough—Sorafenib—kidney cancer	0.00048	0.00663	CcSEcCtD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—kidney cancer	0.000477	0.0136	CbGpPWpGaD
Bromfenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—kidney cancer	0.000469	0.0133	CbGpPWpGaD
Bromfenac—Mediastinal disorder—Vincristine—kidney cancer	0.000463	0.0064	CcSEcCtD
Bromfenac—Cough—Sunitinib—kidney cancer	0.000461	0.00638	CcSEcCtD
Bromfenac—Pain—Vinblastine—kidney cancer	0.000444	0.00613	CcSEcCtD
Bromfenac—Pain—Everolimus—kidney cancer	0.000442	0.00611	CcSEcCtD
Bromfenac—Mediastinal disorder—Gemcitabine—kidney cancer	0.000439	0.00608	CcSEcCtD
Bromfenac—Headache—Temsirolimus—kidney cancer	0.000435	0.00602	CcSEcCtD
Bromfenac—Epistaxis—Paclitaxel—kidney cancer	0.000429	0.00593	CcSEcCtD
Bromfenac—Pain—Erlotinib—kidney cancer	0.000426	0.0059	CcSEcCtD
Bromfenac—Balsalazide—PTGS2—kidney cancer	0.000421	0.053	CrCbGaD
Bromfenac—Asthma—Capecitabine—kidney cancer	0.000418	0.00579	CcSEcCtD
Bromfenac—PTGS2—S1P1 pathway—KDR—kidney cancer	0.000417	0.0119	CbGpPWpGaD
Bromfenac—Headache—Pazopanib—kidney cancer	0.00041	0.00567	CcSEcCtD
Bromfenac—Lumiracoxib—PTGS2—kidney cancer	0.000385	0.0484	CrCbGaD
Bromfenac—Pain—Sorafenib—kidney cancer	0.000384	0.0053	CcSEcCtD
Bromfenac—Eye disorder—Paclitaxel—kidney cancer	0.000381	0.00527	CcSEcCtD
Bromfenac—Cough—Gemcitabine—kidney cancer	0.00037	0.00512	CcSEcCtD
Bromfenac—Pain—Sunitinib—kidney cancer	0.000369	0.0051	CcSEcCtD
Bromfenac—Mediastinal disorder—Paclitaxel—kidney cancer	0.000368	0.00509	CcSEcCtD
Bromfenac—PTGS1—Overview of nanoparticle effects—PTGS2—kidney cancer	0.000367	0.0105	CbGpPWpGaD
Bromfenac—Nepafenac—PTGS2—kidney cancer	0.000366	0.0461	CrCbGaD
Bromfenac—Epistaxis—Capecitabine—kidney cancer	0.000352	0.00487	CcSEcCtD
Bromfenac—PTGS2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000351	0.00998	CbGpPWpGaD
Bromfenac—Fenbufen—PTGS2—kidney cancer	0.000351	0.0441	CrCbGaD
Bromfenac—Pain—Dactinomycin—kidney cancer	0.000349	0.00483	CcSEcCtD
Bromfenac—Eye pain—Doxorubicin—kidney cancer	0.000346	0.00478	CcSEcCtD
Bromfenac—Vision blurred—Paclitaxel—kidney cancer	0.000335	0.00463	CcSEcCtD
Bromfenac—Headache—Vinblastine—kidney cancer	0.000325	0.00449	CcSEcCtD
Bromfenac—Indomethacin—PTGS1—kidney cancer	0.000325	0.0409	CrCbGaD
Bromfenac—Headache—Everolimus—kidney cancer	0.000324	0.00448	CcSEcCtD
Bromfenac—Eye disorder—Capecitabine—kidney cancer	0.000313	0.00433	CcSEcCtD
Bromfenac—Headache—Erlotinib—kidney cancer	0.000312	0.00432	CcSEcCtD
Bromfenac—Pain—Vincristine—kidney cancer	0.000312	0.00432	CcSEcCtD
Bromfenac—Cough—Paclitaxel—kidney cancer	0.00031	0.00429	CcSEcCtD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—kidney cancer	0.000309	0.00879	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CD34—kidney cancer	0.000305	0.0087	CbGpPWpGaD
Bromfenac—Tolmetin—PTGS2—kidney cancer	0.000305	0.0383	CrCbGaD
Bromfenac—PTGS1—Eicosanoid Synthesis—PTGS2—kidney cancer	0.000304	0.00867	CbGpPWpGaD
Bromfenac—Mediastinal disorder—Capecitabine—kidney cancer	0.000302	0.00417	CcSEcCtD
Bromfenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—kidney cancer	0.000301	0.00858	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—ALDH1A1—kidney cancer	0.000299	0.0085	CbGpPWpGaD
Bromfenac—Pain—Gemcitabine—kidney cancer	0.000296	0.0041	CcSEcCtD
Bromfenac—Diclofenac—PTGS1—kidney cancer	0.000293	0.0369	CrCbGaD
Bromfenac—Suprofen—PTGS2—kidney cancer	0.000292	0.0367	CrCbGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR1—kidney cancer	0.000289	0.00822	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000285	0.0081	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000284	0.00808	CbGpPWpGaD
Bromfenac—Headache—Sorafenib—kidney cancer	0.000281	0.00389	CcSEcCtD
Bromfenac—Vision blurred—Capecitabine—kidney cancer	0.000275	0.0038	CcSEcCtD
Bromfenac—Headache—Sunitinib—kidney cancer	0.00027	0.00374	CcSEcCtD
Bromfenac—Asthma—Doxorubicin—kidney cancer	0.00027	0.00373	CcSEcCtD
Bromfenac—Diclofenac—CYP1A1—kidney cancer	0.000268	0.0337	CrCbGaD
Bromfenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—kidney cancer	0.000263	0.0075	CbGpPWpGaD
Bromfenac—Ketoprofen—PTGS1—kidney cancer	0.00026	0.0327	CrCbGaD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.000255	0.00725	CbGpPWpGaD
Bromfenac—Cough—Capecitabine—kidney cancer	0.000254	0.00352	CcSEcCtD
Bromfenac—Pain—Paclitaxel—kidney cancer	0.000248	0.00343	CcSEcCtD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000242	0.00688	CbGpPWpGaD
Bromfenac—PTGS2—S1P1 pathway—VEGFA—kidney cancer	0.00023	0.00653	CbGpPWpGaD
Bromfenac—Headache—Vincristine—kidney cancer	0.000229	0.00316	CcSEcCtD
Bromfenac—Epistaxis—Doxorubicin—kidney cancer	0.000227	0.00314	CcSEcCtD
Bromfenac—PTGS2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000226	0.00643	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000225	0.00642	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—PTGS1—kidney cancer	0.000223	0.00635	CbGpPWpGaD
Bromfenac—PTGS2—S1P1 pathway—MAPK3—kidney cancer	0.000217	0.00618	CbGpPWpGaD
Bromfenac—Headache—Gemcitabine—kidney cancer	0.000217	0.003	CcSEcCtD
Bromfenac—PTGS2—S1P1 pathway—MAPK1—kidney cancer	0.000207	0.00588	CbGpPWpGaD
Bromfenac—Pain—Capecitabine—kidney cancer	0.000203	0.00281	CcSEcCtD
Bromfenac—Eye disorder—Doxorubicin—kidney cancer	0.000202	0.00279	CcSEcCtD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.0002	0.00568	CbGpPWpGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000199	0.00568	CbGpPWpGaD
Bromfenac—Mediastinal disorder—Doxorubicin—kidney cancer	0.000195	0.00269	CcSEcCtD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—kidney cancer	0.000193	0.00548	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	0.000192	0.00546	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—kidney cancer	0.000187	0.00533	CbGpPWpGaD
Bromfenac—Indomethacin—PTGS2—kidney cancer	0.000186	0.0234	CrCbGaD
Bromfenac—Headache—Paclitaxel—kidney cancer	0.000182	0.00251	CcSEcCtD
Bromfenac—Vision blurred—Doxorubicin—kidney cancer	0.000177	0.00245	CcSEcCtD
Bromfenac—PTGS1—Biological oxidations—GSTT1—kidney cancer	0.000175	0.00499	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—ANXA1—kidney cancer	0.000173	0.00493	CbGpPWpGaD
Bromfenac—Aminohippurate—ABCB1—kidney cancer	0.000172	0.0216	CrCbGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000169	0.00482	CbGpPWpGaD
Bromfenac—Diclofenac—PTGS2—kidney cancer	0.000168	0.0211	CrCbGaD
Bromfenac—Cough—Doxorubicin—kidney cancer	0.000164	0.00227	CcSEcCtD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.000161	0.00459	CbGpPWpGaD
Bromfenac—Indomethacin—ABCB1—kidney cancer	0.000158	0.0199	CrCbGaD
Bromfenac—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	0.000157	0.00448	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000155	0.00442	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000155	0.00442	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	0.000152	0.00433	CbGpPWpGaD
Bromfenac—Headache—Capecitabine—kidney cancer	0.000149	0.00206	CcSEcCtD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000149	0.00423	CbGpPWpGaD
Bromfenac—Ketoprofen—PTGS2—kidney cancer	0.000149	0.0187	CrCbGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000148	0.00423	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000148	0.00421	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000147	0.00419	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	0.000145	0.00414	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000145	0.00413	CbGpPWpGaD
Bromfenac—Diclofenac—ABCB1—kidney cancer	0.000143	0.0179	CrCbGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000136	0.00387	CbGpPWpGaD
Bromfenac—Pain—Doxorubicin—kidney cancer	0.000131	0.00181	CcSEcCtD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000128	0.00365	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	0.000125	0.00355	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GSTP1—kidney cancer	0.000122	0.00346	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	0.000121	0.00345	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000118	0.00335	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	0.000117	0.00333	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000115	0.00328	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	0.000113	0.00322	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GSTM1—kidney cancer	0.000112	0.00318	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	0.000111	0.00316	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000108	0.00307	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	0.000106	0.00303	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—CYP1A1—kidney cancer	0.000106	0.00302	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000106	0.00301	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000106	0.00301	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	0.000104	0.00296	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	0.000102	0.0029	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	9.88e-05	0.00281	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	9.62e-05	0.00274	CbGpPWpGaD
Bromfenac—Headache—Doxorubicin—kidney cancer	9.61e-05	0.00133	CcSEcCtD
Bromfenac—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	9.49e-05	0.0027	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ACY1—kidney cancer	9.32e-05	0.00265	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	8.94e-05	0.00254	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	8.8e-05	0.0025	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	8.68e-05	0.00247	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	8.6e-05	0.00245	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	8.4e-05	0.00239	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	8.4e-05	0.00239	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	8.02e-05	0.00228	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.95e-05	0.00226	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PDHB—kidney cancer	7.92e-05	0.00226	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—POMC—kidney cancer	7.9e-05	0.00225	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CCBL1—kidney cancer	7.45e-05	0.00212	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ACY1—kidney cancer	7.4e-05	0.00211	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CCBL1—kidney cancer	7.06e-05	0.00201	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.74e-05	0.00192	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PPAT—kidney cancer	6.46e-05	0.00184	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GLIPR1—kidney cancer	6.46e-05	0.00184	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	6.43e-05	0.00183	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	6.4e-05	0.00182	CbGpPWpGaD
Bromfenac—PTGS2—Disease—AMER1—kidney cancer	6.39e-05	0.00182	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.38e-05	0.00182	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.31e-05	0.0018	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PDHB—kidney cancer	6.29e-05	0.00179	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL2—kidney cancer	6.27e-05	0.00178	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	6.11e-05	0.00174	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.06e-05	0.00172	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—APRT—kidney cancer	6e-05	0.00171	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—FH—kidney cancer	6e-05	0.00171	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	5.94e-05	0.00169	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CCBL1—kidney cancer	5.91e-05	0.00168	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.87e-05	0.00167	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GPC3—kidney cancer	5.65e-05	0.00161	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CA2—kidney cancer	5.49e-05	0.00156	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ALAD—kidney cancer	5.35e-05	0.00152	CbGpPWpGaD
Bromfenac—PTGS2—Disease—GPC3—kidney cancer	5.35e-05	0.00152	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.35e-05	0.00152	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ST3GAL2—kidney cancer	5.22e-05	0.00149	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PPAT—kidney cancer	5.13e-05	0.00146	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GLIPR1—kidney cancer	5.13e-05	0.00146	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ALDH1A1—kidney cancer	5.11e-05	0.00145	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.06e-05	0.00144	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	5.04e-05	0.00143	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.01e-05	0.00143	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ST3GAL2—kidney cancer	4.95e-05	0.00141	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MYC—kidney cancer	4.9e-05	0.00139	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PGK1—kidney cancer	4.89e-05	0.00139	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC5A3—kidney cancer	4.89e-05	0.00139	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—LDHB—kidney cancer	4.8e-05	0.00137	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.79e-05	0.00136	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—APRT—kidney cancer	4.77e-05	0.00136	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—FH—kidney cancer	4.77e-05	0.00136	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.75e-05	0.00135	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.7e-05	0.00134	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.66e-05	0.00133	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SLC5A3—kidney cancer	4.64e-05	0.00132	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PGK1—kidney cancer	4.64e-05	0.00132	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SFRP2—kidney cancer	4.55e-05	0.0013	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LDHB—kidney cancer	4.55e-05	0.0013	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GPC3—kidney cancer	4.48e-05	0.00128	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CA2—kidney cancer	4.36e-05	0.00124	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.36e-05	0.00124	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ALAD—kidney cancer	4.25e-05	0.00121	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TCEB2—kidney cancer	4.24e-05	0.00121	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TCEB1—kidney cancer	4.24e-05	0.00121	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CA9—kidney cancer	4.16e-05	0.00118	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.16e-05	0.00118	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ST3GAL2—kidney cancer	4.15e-05	0.00118	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.15e-05	0.00118	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.11e-05	0.00117	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.07e-05	0.00116	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ALDH1A1—kidney cancer	4.05e-05	0.00115	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TP53—kidney cancer	4.02e-05	0.00115	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.01e-05	0.00114	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC5A3—kidney cancer	3.89e-05	0.00111	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PGK1—kidney cancer	3.89e-05	0.00111	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—LDHB—kidney cancer	3.81e-05	0.00108	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.62e-05	0.00103	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CRABP1—kidney cancer	3.54e-05	0.00101	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RPL14—kidney cancer	3.45e-05	0.000982	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.43e-05	0.000976	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.33e-05	0.000949	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CA9—kidney cancer	3.3e-05	0.000941	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ITPR2—kidney cancer	3.29e-05	0.000937	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.26e-05	0.000928	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.23e-05	0.000919	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ITPR2—kidney cancer	3.12e-05	0.000888	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.08e-05	0.000877	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.03e-05	0.000863	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTT1—kidney cancer	3e-05	0.000854	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ACHE—kidney cancer	3e-05	0.000854	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SCARB1—kidney cancer	2.84e-05	0.000809	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.83e-05	0.000806	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CRABP1—kidney cancer	2.81e-05	0.0008	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PSMD7—kidney cancer	2.76e-05	0.000785	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.74e-05	0.000779	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—BCHE—kidney cancer	2.61e-05	0.000744	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PSMD7—kidney cancer	2.61e-05	0.000744	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ITPR2—kidney cancer	2.61e-05	0.000744	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC5A5—kidney cancer	2.58e-05	0.000735	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC2A1—kidney cancer	2.49e-05	0.00071	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.42e-05	0.000689	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.41e-05	0.000685	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTT1—kidney cancer	2.38e-05	0.000678	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ACHE—kidney cancer	2.38e-05	0.000678	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SLC2A1—kidney cancer	2.36e-05	0.000673	CbGpPWpGaD
Bromfenac—PTGS2—Disease—JUNB—kidney cancer	2.35e-05	0.000668	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SCARB1—kidney cancer	2.25e-05	0.000642	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PTGS1—kidney cancer	2.23e-05	0.000635	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PSMD7—kidney cancer	2.19e-05	0.000623	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.11e-05	0.000601	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTP1—kidney cancer	2.08e-05	0.000592	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—BCHE—kidney cancer	2.07e-05	0.000591	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC5A5—kidney cancer	2.05e-05	0.000583	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC2A1—kidney cancer	1.98e-05	0.000564	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ABCB1—kidney cancer	1.97e-05	0.00056	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTM1—kidney cancer	1.91e-05	0.000544	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN2B—kidney cancer	1.91e-05	0.000544	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CYP1A1—kidney cancer	1.81e-05	0.000516	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.67e-05	0.000477	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTP1—kidney cancer	1.65e-05	0.00047	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ABCB1—kidney cancer	1.56e-05	0.000445	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HIF1A—kidney cancer	1.53e-05	0.000435	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TSC2—kidney cancer	1.52e-05	0.000434	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTM1—kidney cancer	1.52e-05	0.000432	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.49e-05	0.000424	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYP1A1—kidney cancer	1.44e-05	0.000409	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—POMC—kidney cancer	1.35e-05	0.000385	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KIT—kidney cancer	1.35e-05	0.000383	CbGpPWpGaD
Bromfenac—PTGS2—Disease—APC—kidney cancer	1.35e-05	0.000383	CbGpPWpGaD
Bromfenac—PTGS2—Disease—BRAF—kidney cancer	1.26e-05	0.00036	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.18e-05	0.000336	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTGS2—kidney cancer	1.08e-05	0.000307	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—POMC—kidney cancer	1.07e-05	0.000305	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RAF1—kidney cancer	1.06e-05	0.000301	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ERBB2—kidney cancer	1.04e-05	0.000297	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MTOR—kidney cancer	1.03e-05	0.000293	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CD4—kidney cancer	1.03e-05	0.000293	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN1B—kidney cancer	9.67e-06	0.000275	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTEN—kidney cancer	9.4e-06	0.000267	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CTNNB1—kidney cancer	9.14e-06	0.00026	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PTEN—kidney cancer	8.91e-06	0.000254	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MAPK3—kidney cancer	7.61e-06	0.000217	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PTEN—kidney cancer	7.46e-06	0.000212	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MYC—kidney cancer	7.4e-06	0.000211	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MAPK1—kidney cancer	7.24e-06	0.000206	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KRAS—kidney cancer	6.84e-06	0.000195	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CA—kidney cancer	6.63e-06	0.000189	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CA—kidney cancer	6.28e-06	0.000179	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CA—kidney cancer	5.26e-06	0.00015	CbGpPWpGaD
